ロード中...
High levels of serum glypican‐1 indicate poor prognosis in pancreatic ductal adenocarcinoma
Carbohydrate antigen 19‐9 (CA19‐9) fails to demonstrate the predictive value for early detection pancreatic ductal adenocarcinoma (PDAC). Glypican‐1 (GPC1+) exosomes may serve as a noninvasive diagnostic tool to detect early stages of PDAC. Therefore, it is necessary to explore the serum GPC1 levels...
保存先:
| 出版年: | Cancer Med |
|---|---|
| 主要な著者: | , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
John Wiley and Sons Inc.
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6246926/ https://ncbi.nlm.nih.gov/pubmed/30358133 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.1833 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|